Mimedx (MDXG) Total Debt Growth (5y) (2016 - 2026)
Mimedx (MDXG) Total Debt Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Mimedx | 639.80 Mn | 480.03 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.85% |
| Dec 31, 2025 | -17.74% |
| Sep 30, 2025 | -17.49% |
| Jun 30, 2025 | -24.59% |
| Mar 31, 2025 | -22.18% |
| Dec 31, 2024 | -22.10% |
| Sep 30, 2024 | -24.56% |
| Jun 30, 2024 | -21.09% |
| Jun 30, 2022 | 22.44% |
| Mar 31, 2022 | 40.73% |
| Dec 31, 2021 | 42.26% |
| Sep 30, 2021 | 38.98% |
| Jun 30, 2021 | 37.80% |
| Jun 30, 2017 | 53.80% |
| Mar 31, 2017 | 37.49% |
| Dec 31, 2016 | 27.78% |
| Sep 30, 2016 | 50.03% |
| Jun 30, 2016 | 50.69% |